PubMed · 999761
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
L Strunin. 1976. Hepatitis and halothane.. https://doi.org/10.1093/bja%2F48.11.1035
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Serum alpha-glutathione S-transferase (alpha-GST) has been shown to be a sensitive marker of liver injury. We compared the relationship of both serum alpha-GST and alanine transaminase (ALT) with liver biopsy inflammatory activity in patients who had chronic hepatitis C infection (HCV), and examined the effects of alpha-interferon therapy on serum alpha-GST and ALT concentrations. Of 32 patients with chronic HCV infection studied, 17 received alpha-interferon 4.5 MU three times per week for 3 months and 15 acted as controls. Liver biopsy just prior to treatment was scored for the grade of inflammation (Scheuer histological activity index). Serum alpha-GST and ALT were assayed just prior to biopsy and 3 months later. Neither serum alpha-GST nor ALT levels showed any correlation with baseline inflammation on liver biopsy. alpha-Interferon significantly reduced serum alpha-GST concentration at 3 months (P = 0.01). ALT fell with treatment but not significantly (P = 0.05). Small falls in alpha-GST and ALT were noted in the control group, and when these were considered the significance of the changes in alpha-GST and ALT with treatment was lost (P = 0.35 and P = 0.09, respectively). This study shows that serum alpha-GST is not a useful marker of the degree of liver inflammation in chronic HCV infection, though it may be of more value than ALT in monitoring response to treatment with alpha-interferon.
Cytokine gene expression in the liver of transgenic mouse which specifically expresses interferon-gamma gene (IFN-gamma) was measured using polymerase chain reaction analysis. IFN-gamma mRNA was found to be expressed in the transgenic mouse liver along with TNF-alpha mRNA. Messenger RNAs of CD4 and CD8, maturation markers of T cells, were expressed in both normal and transgenic mouse livers, indicating the presence of resident T cells. The level of CD4 and CD8 expression was slightly elevated in the transgenic mouse case, indicating an increased number of CD4+ and/or CD8+ T cells, but the lack of the activation marker IL-2 mRNA suggested a nonactivated state. TGF-beta 1 mRNA was expressed in both normal and transgenic mouse livers without any increase in the latter, and therefore does not appear to be involved in the development of chronic active hepatitis in this transgenic mouse. Since TNF-alpha is a terminal mediator of liver injury in several animal liver injury models, its high expression, presumably a result of the IFN-gamma which is transcribed from the introduced gene, might be involved in the development of chronic active hepatitis in this transgenic mouse.
Numerous studies have reported successful allotransplantation of hepatocytes. However, none have shown long-term correction of a liver-related metabolic defect. In this study, we used a method of regional hepatocyte transplantation and subsequent induction of transplanted cell proliferation by regeneration response in the transplant-bearing liver lobes. New Zealand White rabbits were used as cell donors and Watanabe heritable hyperlipidemic (WHHL) rabbits were used as cell recipients (2 x 10(8) cells/rabbit). All recipient rabbits were maintained on daily cyclosporine. Two weeks after baseline serum cholesterol determination, group I WHHL rabbits (n = 7) received an infusion of cells into the right lateral liver lobe, and a loose ligature was placed around the portal venous branch supplying the anterior lobe. After 1 week, to allow engraftment, the portal venous branch was ligated, which resulted in the atrophy of the affected liver parenchyma and induction of hyperplasia in the transplant-bearing liver tissue. Group II rabbits (n = 6) were transplanted with New Zealand White hepatocytes without portal branch ligation (PBL) and group III rabbits (n = 4) were subjected to sham transplantation (saline) and PBL. The experimental period extended to 150 days after transplantation. All WHHL rabbits transplanted with normal hepatocytes showed reduction in serum cholesterol and low-density lipoprotein (LDL) levels. Group I (PBL-stimulated) recipients demonstrated a more pronounced and sustained effect than group II animals (P < 0.05). Group III controls showed only a slight, typical for aging decrease in serum cholesterol. Group I recipient livers perfused with LDL labeled with 1,1'-dioctadecyl-3,3,3',3'-tetramethyl indocarbocyanine perchlorate (DiI) showed much higher numbers of DiI-LDL-positive hepatocytes than those of group II recipients. In conclusion, a liver regeneration stimulus enhanced the population of transplanted hepatocytes and their functional effect in a large animal model of inborn error of liver metabolism.